Key Takeaways
- Bioethics research student Caleb Atere argues that competitive workplaces may indirectly pressure workers to use cognitive enhancers, even without employer orders.
- Atere warns that workers in insecure or junior roles may feel less able to refuse enhancers because falling behind could affect jobs and income.
- Atere recommends workplace policies protecting workers who reject cognitive enhancers, better schedules and workloads, and independent information about benefits and risks.
Nobody is being forced to take a smart drug. No employer has issued a memo demanding sharper focus through chemistry. Yet in some of the most competitive workplaces, a quieter kind of pressure may be building: the feeling that if your colleagues are enhancing their minds, you cannot afford not to.
From choice to expectation
Cognitive enhancement is usually discussed as a personal choice. A person decides to take a stimulant, try a nootropic, or use a brain-stimulation device, and accepts the risks and benefits that come with it. On paper, that sounds like freedom.
But choices are rarely made in a vacuum. Consider a hospital where overnight shifts are long and errors are costly, or a law firm where billable hours decide promotions, or a newsroom with relentless deadlines. If some workers begin using enhancers to stay alert and productive, the baseline for “good performance” can shift. Others may feel pushed to follow, not because they want to, but because falling behind has real consequences for their jobs and income.
Ethicists sometimes call this indirect coercion. No one is ordered to enhance, yet the surrounding conditions make refusing feel like a professional risk.
We have seen this pattern before
Workplaces have long normalized habits that began as optional. Constant email availability started as a convenience and gradually became an expectation. Heavy caffeine use is so common that few people question it. Cognitive enhancement could follow a similar path: from unusual, to common, to quietly assumed.
The difference is that enhancement can involve prescription drugs, unknown long-term effects, and medical risks that coffee does not. When the stakes are higher, the question of whether people are truly free to say no becomes more important.
Who is most vulnerable?
Not every worker feels the same pressure. Those in insecure jobs, junior roles, or industries with heavy competition may feel they have less room to refuse. Workers who cannot easily switch employers or who depend on every promotion may be more likely to experiment with enhancement even when they have doubts.
This also connects to the inequality concerns raised earlier in this series. Those who can afford safer, better-quality enhancers may gain an advantage, while others may turn to cheaper, riskier options just to keep pace.
